We were delighted to host Dr Briana De Miranda on the topic of "How the environment affects Parkinson's Disease and what you can do about it."

As Parkinson's diagnoses continue to rise worldwide, increasing attention is being given to the role of environmental factors in the disease's onset and progression, and to the practical steps we can take to better protect ourselves from these risks.

Briana De Miranda, Ph.D., is a Neurotoxicologist and Associate Professor of Neurology in the Killion Center for Neurodegeneration at the University of Alabama at Birmingham. Her research focuses on environmental risks for neurodegenerative diseases, integrating expertise in toxicology, pharmacology, and neuroscience. Her interdisciplinary research is aimed at understanding how neurodegeneration is caused by environmental exposures, and finding ways to treat or prevent neurologic disorders caused by toxic risk factors.

More about the speaker:-

https://scholars.uab.edu/16563-briana-de-miranda

https://www.parkinson.org/living-with-parkinsons/stories/briana-de-miranda

https://www.linkedin.com/in/briana-de-miranda-3196a231

https://www.sciencedirect.com/science/article/pii/S0969996121000619

We were delighted to host Carl Beech, the creator of the Beech Band, a new wearable device to manage Parkinson’s symptoms.

Carl was 51 when he was diagnosed with Young-Onset Parkinson’s.  He began to experience slurring and a rapidly worsening stammer. Faced with the loss of speech, he nearly gave up hope. But then, while experimenting with a therapeutic tapping technique, he had a personal breakthrough – rhythmic tapping allowed him to regulate his speech and relieve his stammer. This led to an idea: what if this could be turned into a wearable device that could help many more people?

Today, Carl will be sharing his experience with the Beech Band.

After 13 months of wearing the device Carl has experienced remarkable changes to his symptoms. Since its release in July over 15,000 have been sold and there have been very positive reactions from user. Whilst this story is inspiring and hopeful,  it’s important to remember that Parkinson’s is complex, and no single approach works for everyone and that the positive responses are anecdotal.


The Beech Band is a wellness device, not a medical treatment, so please speak with your medical team if you have any concerns about using the device or are considering any changes to your medication.

More information on the device can be found here:-

https://www.beechband.com/
https://www.facebook.com/p/BeechBand-61563836532593/
https://www.instagram.com/beechband/?hl=en
https://www.tiktok.com/@beechband

We are delighted to once again host Dr. Matthew Phillips, who presented on:

"Optimising Parkinson’s: Essential Therapies".

Matt joined us first back in Feb 2023 when he presented "Intermittent Fasting & Keto & Diet Strategies" which has had over 100,000 views since and can still be watched on our YouTube channel

 https://www.youtube.com/@nosilverbullet4pd998/videos

In this new session, Dr Phillips will offer a broader framework to help people with Parkinson’s navigate and combine various therapeutic options, going well beyond the fasting and ketogenic protocols explored in his previous talks. 

We are delighted to share this update from Dr Sackner-Bernstein, following his previous webinar titled “Why I Am Optimistic That We Might Have a Silver Bullet for PD.”

In this new update, he builds on the key ideas from his earlier presentation and shares the latest developments that continue to fuel his optimism.

Dr Sackner-Bernstein is the author of a 2021 peer-reviewed study published in The Journal of Parkinson’s Disease, where he proposed that the standard treatment approach to Parkinson’s might actually be the opposite of what is most effective. We had the pleasure of hosting him last year, and we’re excited to hear his latest insights.

If you’d like a deeper dive into this topic, you can find our full conversation from June last year on our YouTube channel.

Please note: This content is for informational and educational purposes only. For medical advice, please consult your healthcare provider.

Thank you,
The No Silver Bullet Team

We are delighted to share with you our latest recording  featuring Dr. Alfonso Fasano, a world-renowned neurologist and researcher, presenting “New Allies Against Parkinson’s: Adaptive DBS & Subcutaneous Foslevodopa”.


🌟 What to Expect

This webinar will explore two groundbreaking treatments that are changing the landscape of Parkinson’s care:

• Adaptive Deep Brain Stimulation (aDBS): Learn how this technology personalizes stimulation in real time to better manage symptoms and reduce side effects.
  
  
• Subcutaneous Foslevodopa: Discover how this new delivery method could offer smoother and more continuous relief from motor fluctuations, potentially replacing traditional oral medications.
  
  

👨‍⚕️ About the Speaker

Dr. Alfonso Fasano is a neurologist specializing in movement disorders, with roles in both Italy and Canada. He is Professor of Neurology at Humanitas University and Head of Neurology at Humanitas Research Hospital in Milan. He also holds a professorship in the Department of Medicine (Division of Neurology) at the University of Toronto and is a staff neurologist at Toronto Western Hospital and the Hospital for Sick Children.

Dr. Fasano’s main research interests include using advanced technologies—such as infusion pumps and brain stimulation—to treat Parkinson’s disease, tremor, and walking disorders. He has published over 500 scientific articles, and serves on the editorial boards of leading journals in neurology and movement disorders. He is also actively involved in clinical trials and international research groups.

"Women’s Health & Parkinson’s", a special webinar in collaboration with the PD Buddy App in now available as a Podcast

This session explores the connection between menopause, hormones, and Parkinson’s, providing valuable insights and practical strategies to help you navigate these changes.

Led by Dr. Tanya Denne, ND, a naturopathic doctor and researcher, the webinar covers key topics such as hormone replacement therapy (HRT), fatigue, nutrition, gut health, and more. Through evidence-based approaches and real-world case studies, Dr. Denne bridges the gap between neurology, primary care, and holistic wellness—offering tangible takeaways to help you optimise your health and care plan.

This event is brought to you in partnership with the PD Buddy App (https://pdbuddy.app/ a free digital tool designed to support people with Parkinson’s and their caregivers. PD Buddy helps you organise routines, track symptoms, and access expert resources, making it easier to manage day-to-day life with Parkinson’s.

If you have questions following this webinar, please do not hesitate to contact Dr Denne on:
DoctorDenne.com
[email protected]

We were delighted to welcome Dr. Wayne Markman, CEO of SYMBYX, for an insightful update on the latest clinical trials using light therapy to ease Parkinson’s symptoms. SYMBYX stands out for its strong focus on evidence-based innovation, investing significantly in medical research to better understand and validate the role of light therapy in Parkinson’s care.

For a deeper dive into the science and potential benefits, check out our earlier interview with Dr. Markman from November 2023 on our YouTube channel.

This session is intended for informational and educational purposes only. If you're seeking medical advice, please consult a healthcare professional.

Thank you to Prof Malu Tansey who joined us to share her expertise on the topic of "Inflammation and Parkinson's and what we can do about it"

This presentation was excellent and we encourage you to watch it and the Q&A that followed as you will certainly come away with a better understanding of this complicated topic.

About the Speaker:-

Malú Gámez Tansey, Ph.D., is a Professor of Neurology and the James Caplin Chair in Alzheimer’s Disease at Indiana University School of Medicine and Director of Neuroimmunology Research Group & Executive Associate Director of Education at the Stark Neuroscience Research Institute.

Her lab focuses on the role of inflammation and immune system responses in brain health and neurodegenerative disease, with particular focus on central-peripheral neuroimmune crosstalk and the gut-brain axis, with the long-term goal of developing better therapies to prevent and/or delay these diseases.

Dr. Tansey obtained her B.S/M.S in Biological Sciences from Stanford University and her Ph.D. in Cell Regulation from UT Southwestern, followed by post-doctoral work in neuroscience at Washington University. 

She returned to academia as an Assistant Professor of Physiology at UT Southwestern in 2002 and was recruited to Emory University School of Medicine as a tenured Associate Professor in 2009. After 10 years at Emory and rising to the rank of Full Professor, in 2019, she was recruited to the Department of Neuroscience in the College of Medicine at the University of Florida as the Fixel Chair in Neuroscience and Neurology and Director of the Centre for Translational Research in Neurodegenerative Disease. She also served on the executive committees for the McKnight Brain Institute and the Fixel Institute for Neurological Diseases.

We recently hosted two webinars on Mucuna pruriens, a tropical legume rich in levodopa. The first, with Dr. Roberto Cilia, focused on the use of Mucuna in low-income countries where levodopa is often unavailable or unaffordable. The second, with Dr. Rafael Maldonado, took a broader perspective. Due to continued interest and questions on mucuna, we organised today’s session with Dr. Tanya Denne.

Since 2010, Dr. Denne has researched Mucuna for its potential in treating Parkinson's.  Having been mentored by Dr. Laurie Mischley, she chose her Naturopathic Medical School with a focus on serving the Parkinson's community.

Dr. Denne treats the whole person with a personalized, holistic approach and specializes in optimizing care plans and addressing treatment gaps. Driven by her passion for public health, she joined Dr. Roberto Cilia in Ghana in February to help tackle Parkinson's care in countries where Mucuna is sometimes all they have. 

This session is intended for informational and educational purposes only. If you're seeking medical advice, please consult a healthcare professional. 

For those who are new to us, “No Silver Bullet” is managed by Mark Limebear and myself, with the goal of sharing valuable Parkinson's expertise.

Our mission is to empower you with knowledge and motivation to make informed choices about adapting your lifestyle to manage your symptoms and slow disease progression.

We also share recordings of our webinars on YouTube and Spotify. You can find the details on our website: nosilverbullet4pd.com.

If you have questions following this webinar, please do not hesitate to contact Dr Denne on:
DoctorDenne.com
[email protected]

We are delighted to share with you our latest recording "A new Parkinson's test- hope or hype?" a webinar on the alpha-synuclein seed amplification assay (αSyn-SAA), presented by the M J Fox Foundation as a significant breakthrough in the search for a Parkinson's biomarker.

With the growing interest surrounding αSyn-SAA, it’s crucial for patients and their families to understand both its potential benefits and limitations.

About the Speaker:-

Dr. Alberto Espay is Professor and Endowed Chair of the James and Joan Gardner Center for Parkinson's Disease at the University of Cincinnati.

He has published over 300 research articles and 8 books, including Common Movement Disorders Pitfalls, which received the Highly Commended BMA Medical Book Award in 2013 and Brain Fables, the Hidden History of Neurodegenerative Diseases and a Blueprint to Conquer them, co-authored with Parkinson's patient and advocate Benjamin Stecher, selected by the Association of American Publishers for the PROSE Award honouring the best scholarly work in Neuroscience published in 2020.

With colleagues at the University of Cincinnati, he recently launched the first biomarker study of aging (CCBPstudy.com), designed to match people with neurodegenerative disorders to available therapies from which they are most biologically suitable to benefit, regardless of their clinical diagnoses.